Date posted: August 9, 2024, 4:00 pm
In this episode, we discuss the approach to deprescribing for several drugs such as benzodiazepine receptor agonists, cholinesterase inhibitors, memantine, antipsychotics, and antihyperglycemics.
Date posted: June 28, 2024, 6:00 am
In this episode, we review the pharmacology, pharmacokinetics, adverse effects, monitoring, medicinal chemistry, and more of loop diuretics.
Date posted: May 7, 2024, 6:00 am
In this episode, we discuss principles for medication use in the geriatric patient population and summarize the updated 2023 American Geriatrics Society Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.
Date posted: April 16, 2024, 6:00 am
In this episode, we discuss artificial intelligence large language models (LLMs) and how these will impact the future of the practice of pharmacy.
Date posted: March 26, 2024, 6:00 am
In this episode, we review the pharmacology, indications, adverse effects, monitoring, and unique drug characteristics of HMG CoA reductase inhibitors (“statins”).
Date posted: March 5, 2024, 6:00 am
In this recurring episode, we discuss the important updates from the 2024 American Diabetes Association Guidelines!
Date posted: February 13, 2024, 6:00 am
In this episode, we speak with Janeen Winnike, the Associate Dean for Student Affairs at Ë®ÃÛÌÒÊÓƵ Franklin and a co-course director for the Pharmacy Law course at the university. We review some of the key points regarding federal and Illinois pharmacy law – a must-listen especially for graduates preparing for their MPJE exam after graduation!
Date posted: January 23, 2024, 6:00 am
In this episode, we review evidence-based guidelines for the emergency reversal of warfarin, dabigatran, and the oral Xa inhibitors (apixaban, edoxaban, and rivaroxaban).
Date posted: January 2, 2024, 6:00 am
In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives with a brief focus on the very first FDA approved OTC hormonal contraceptive product (Opill).
Date posted: December 13, 2023, 11:00 am
In this two part episode, we review some of the most important clinical pearls in the pharmacotherapy and practice aspects of hormonal contraceptives with a brief focus on the very first FDA approved OTC hormonal contraceptive product (Opill).